Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH APPROACH 
           2.1.1 SECONDARY SOURCES
           2.1.2 PRIMARY SOURCES
    2.2 MARKET SIZE ESTIMATION METHODOLOGY 
    2.3 MARKET ESTIMATION 
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION 
    2.5 ASSUMPTIONS FOR THE STUDY 
    2.6 RISK ASSESMENT 
    2.7 LIMITATION 
    2.8 RECESSION IMPACT ON CLINICAL DECISION SUPPORT SYSTEM MARKET 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 CASE STUDIES 
    5.4 ECOSYSTEM ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS 
    5.7 TARIFF & REGULATORY ANALYSIS 
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
    5.8 PORTERS FIVE FORCES ANALYSIS 
    5.9 INDUSTRY TRENDS 
    5.9 PRICING ANALYSIS 
           5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
           5.9.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.10 KEY CONFERENCES & EVENTS, 2023-2024 
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.11.2 BUYING CRITERIA
    5.12 PATENT ANALYSIS 
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT 
    6.1 INTRODUCTION 
    6.2 SERVICES 
    6.3 SOFTWARE 
    6.4 HARDWARE 
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT 
    7.1 INTRODUCTION 
    7.2 INTEGRATED CDSS 
    7.3 STANDALONE CDSS 
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE 
    8.1 INTRODUCTION 
    8.2 THERAPEUTIC CDSS 
    8.3 DIAGNOSTIC CDSS 
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL 
    9.1 INTRODUCTION 
    9.2 KNOWLEDGE-BASED CDSS 
    9.3 NON-KNOWLEDGE-BASED CDSS 
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE 
     10.1 INTRODUCTION 
     10.2 ON-PREMISE CDSS 
     10.3 CLOUD-BASED CDSS 
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION 
     11.1 INTRODUCTION 
     11.2 CONVENTIONAL CDSS 
     11.3 ADVANCED CDSS 
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY 
     12.1 INTRODUCTION 
     12.2 ACTIVE CDSS 
     12.3 PASSIVE CDSS 
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING 
     13.1 INTRODUCTION 
     13.2 INPATIENT SETTINGS 
     13.3 AMBULATORY CARE SETTINGS 
15 CLINICAL DECISION SUPPORT SYSTEM MARKET, BY REGION  
     15.1 INTRODUCTION 
     15.2 NORTH AMERICA 
             15.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
             15.2.2 US
             15.2.3 CANADA
     15.3 EUROPE 
             15.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
             15.3.2 GERMANY
             15.3.3 UK
             15.3.4 FRANCE
             15.3.5 SPAIN
             15.3.6 ITALY
             15.3.7 REST OF EUROPE
     15.4 ASIA PACIFIC 
             15.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
             15.4.2 JAPAN
             15.4.3 CHINA
             15.4.4 INDIA
     15.4. REST OF ASIA PACIFIC 
     15.5 ROW 
             15.5.1 ROW: IMPACT OF ECONOMIC RECESSION
             15.5.2 MIDDLE EAST AND AFRICA
             15.5.3 LATIN AMERICA
16 COMPETITIVE LANDSCAPE 
     16.1 OVERVIEW 
     16.2 KEY PLAYER STRATERGIES 
     16.3 REVENUE SHARE ANALYSIS 
     16.4 MARKET SHARE ANALYSIS 
     16.5 COMPETITIVE BENCHMARKING 
     16.6 COMPETITIVE LEADERSHIP MAPPING  
             16.6.1 STAR
             16.6.2 EMERGING LEADERS
             16.6.3 PERVASIVE PLAYERS
             16.6.4 PARTICIPANTS
     16.7 COMPETITIVE LEADERSHIP MAPPING -START UPS 
             16.7.1 PROGRESSIVE COMPANIES
             16.7.2 STARTING BLOCKS
             16.7.3 RESPONSIVE COMPANIES
             16.7.4 DYNAMIC COMPANIES
     16.8 COMPETITIVE SITUATION & TRENDS  
             16.8.1 PRODUCT LAUNCHES
             16.8.2 DEALS
             16.8.3 OTHERS
17 COMPANY PROFILES 
(Business Overview, Financials, Recent Developments, MnM View)
     17.1 COMPANY PROFILES 
             17.1.1 ORACLE
             17.1.2 MERATIVE 
             17.1.3 CHANGE HEALTHCARE
             17.1.4 VERADIGM,INC. 
             17.1.5 ATHENAHEALTH
             17.1.6 EPIC SYSTEMS CORPORATION
             17.1.7 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
             17.1.8 ZYNX HEALTH 
             17.1.9 WOLTERS KLUWER HEALTH
             17.1.10 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
             17.1.11 MEDITECH
             17.1.12 NEXTGEN HEALTHCARE 
             17.1.13 SIEMENS HEALTHINEERS
             17.1.14 GE HEALTHCARE 
             17.1.15 RAMPMEDICAL 
             17.1.16 MEDICAL ALGORITHMS COMPANY 
             17.1.17 HERA-MI 
             17.1.18 ECLINICALWORKS
             17.1.19 CUREMD
             17.1.20 EBSCO INFORMATION SERVICES
     17.2 OTHER PLAYERS  
             17.2.1  CARE CLOUD
             17.2.2 VISUALDX
             17.2.3 STANSON HEALTH
             17.2.4 FIRST DATA BANK
             17.2.5 STRATA DECISION TECHNOLOGY
18 APPENDIX 
NOTE:  
The segmentation given may change depending upon research findings 
The list of companies mentioned above is indicative only and may change as per further research findings. Key 10-12 companies will be profiled in this section. Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies 
Years considered for the study would be Historical year – 2021, Base Year – 2022, Estimated ‘’Year – 2023, Forecast Period – 2023 to 2028 
The market tables would include value data in USD for the years 2021, 2022,2023 and forecasted value for 2028 along with CAGR for the period 2023-2028